Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

264
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
264
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

1.1K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

290
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
290
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

279
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
279
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

251
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
251
Preparation and Reactions of Thiols02:33

Preparation and Reactions of Thiols

6.9K
Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, Synthesis, and Antimalarial Evaluation of Novel Quinazolin-4(3<i>H</i>)‑one Derivatives with Molecular Modeling Insights into Target Selectivity.

ACS omega·2026
Same author

Ribifolones A-H, New Macrocyclic Diterpenes from <i>Jatropha ribifolia</i>, Their Cytotoxic Activity and Insights Supported by Network Pharmacology and Molecular Modeling.

Molecules (Basel, Switzerland)·2026
Same author

Guanidines: Privileged Scaffolds Against Neglected Tropical Diseases: A Review.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Computational Identification of Potential Novel Allosteric IHF Inhibitors Using QSAR Modeling to Inhibit Plasmid-Mediated Antibiotic Resistance.

International journal of molecular sciences·2026
Same author

Biological and Teratogenic Evaluations of Nitrogen Heterocycles for Anticancer Therapy.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Nanostructured Lipid Carriers Containing Norfloxacin and 2-Aminothiophene Derivative Reduces Fluoroquinolone Resistance in Multidrug-Resistant <i>Staphylococcus aureus</i> Strains by Efflux Pump Inhibition.

Pharmaceutics·2026

Related Experiment Video

Updated: Oct 25, 2025

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.4K

Thiophene-Based Compounds with Potential Anti-Inflammatory Activity.

Ryldene Marques Duarte da Cruz1, Francisco Jaime Bezerra Mendonça-Junior1,2, Natália Barbosa de Mélo2

  • 1Post-Graduation Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil.

Pharmaceuticals (Basel, Switzerland)
|August 6, 2021
PubMed
Summary

Thiophene derivatives show promise as novel anti-inflammatory agents, offering new therapeutic strategies beyond symptom management for chronic inflammatory diseases. Their structure-activity relationships highlight key functional groups for inhibiting key inflammatory enzymes.

Keywords:
anti-inflammatory drugscyclooxygenaseinflammationlipoxygenasemolecular dockingthiophene

More Related Videos

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
03:29

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

689
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.4K

Related Experiment Videos

Last Updated: Oct 25, 2025

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.4K
Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
03:29

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

689
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.4K

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Chemoinformatics

Background:

  • Chronic inflammatory diseases like rheumatoid arthritis, arthrosis, and gout pose significant public health challenges.
  • Current treatments, primarily Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), offer symptomatic relief but have severe side effects and do not promote cure.
  • Advances in drug discovery present opportunities for developing novel anti-inflammatory agents.

Purpose of the Study:

  • To review the role of thiophene derivatives in inflammation.
  • To update on the mechanisms of action and structure-activity relationships of thiophene-based anti-inflammatory agents.
  • To highlight thiophene derivatives as privileged structures for novel drug development.

Main Methods:

  • Review of existing literature on thiophene derivatives and inflammation.
  • Analysis of studies on mechanisms of action, including interactions with cyclooxygenase (COX) and lipoxygenase (LOX) enzymes.
  • Discussion of structure-activity relationships (SAR) of thiophene-based compounds.

Main Results:

  • Thiophene derivatives are identified as privileged structures for anti-inflammatory drug design.
  • Studies confirm the anti-inflammatory properties of thiophene-based compounds.
  • Key structural features, including carboxylic acids, esters, amines, amides, methyl, and methoxy groups, are crucial for activity and target recognition.

Conclusions:

  • Thiophene-based compounds are important for designing novel anti-inflammatory agents.
  • These compounds effectively inhibit key inflammatory enzymes like COX and LOX.
  • Functional groups on thiophene derivatives are critical for their anti-inflammatory activity and target binding.